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Nigeria: stage at presentation and acceptance of
treatment
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Abstract
Background: To determine the stage of primary open angle glaucoma at presentation at a tertiary eye unit, to
assess patient’s knowledge of glaucoma and acceptance and subsequent adherence to treatment.
Method: Information collected prospectively on new glaucoma patients aged 30 or more years included distance
from residence and what they knew about glaucoma and its treatment. Treatment offered took account of disease
severity and socioeconomic factors. Reasons for not accepting surgery were recorded. At follow up intraocular
pressure (IOP) was measured and adherence to medication assessed verbally. Four categories of severity were
defined based on visual acuity and visual fields defects in the worse eye.
Results: 131 patients were recruited (mean age 52.8 years; 62 % male). Most attended because of symptoms (70 %).
Mean IOP in affected eyes was 31.9+/-SD 12.4 and mean vertical cup:disc ratio was 0.8. 99 eyes (47 %) had a visual
acuity of light perception or worse. Risk factors for advanced/end-stage disease were age >50 years, living >10 km from
the hospital, some awareness of glaucoma, not being literate, being unemployed and presenting with symptoms. In
multivariable analysis older age and poor knowledge of glaucoma remained independent risk factors. 75 were offered
trabeculectomy: five agreed but only one underwent surgery. Reasons for rejecting surgery were fear (37 %), preferred
medical treatment (27 %) and cost (15 %). 32/85 (24 %) participants started on topical medication attended follow up.
72 % reported excellent compliance but only 56 % of glaucomatous eyes had IOPs less than 21mmHg.
Conclusions: To prevent glaucoma blindness strategies are required which promote earlier detection, with counselling
to promote acceptance of and adherence to treatment.
Background
Glaucoma causes irreversible blindness in 4.6-6.7 mil-
lion people worldwide [1]. In 2010 there were estimated
to be 60.5 million people with glaucoma, which will
reach 76.0 million by 2020 and 111.8 million by 2040.
Primary open angle glaucoma (POAG) is the common-
est form in Africa with the highest prevalence of any
region (4.20 %; 95 % CI, 2.08-7.35) [2, 3]. The glaucoma-
specific blindness prevalence in adults is estimated to be
eight times higher in the two World Health Organization
(WHO) African sub-regions than the Western Pacific
region, which has the lowest prevalence [4]. In Nigeria,
the prevalence of glaucoma is 5.02 % in adults 40 years
and above (Kyari F, Entekume G, Rabiu M, Spry P et al.
A population-based survey for the prevalence and types
of glaucoma in Nigeria. The Nigeria national blindness
and visual impairment survey. Submitted).
In many African patients, knowledge of the disease is
poor as are acceptance of surgery and adherence to topical
medication [5, 6]. Reasons for poor adherence include fear,
lack of understanding that sight cannot be restored, and
poverty. Community and family factors also contribute, as
individuals’ decisions about expenditure on health impact
on family resources leading to considerable delay in acces-
sing treatment, if at all [7, 8]. This means that patients
often present blind and at a relatively young age, as has
been reported from several countries in Africa (Table 1).
The purpose of this study was to determine the stage
of POAG at presentation at a tertiary eye unit in Nigeria,
to assess patient’s knowledge of the disease and their ac-
ceptance and subsequent adherence to treatment, and to
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explore associations between stage at presentation and
mode of presentation and socio-demographic variables.
The study was undertaken in Abubakar Tafawa Balewa
University Teaching Hospital, (ATBUTH) Bauchi north-
east Nigeria. The catchment area (i.e. within 250 km) is
arid, with a population of approximately 4.3 million. The
majority are Hausa speaking subsistence farmers, and edu-
cation levels amongst adults are low (e.g. 65.7 % literacy in
any language; 26.6 % in English) [9]. Life expectancy is
approximately 48 years [10]. Poverty levels are high and
infrastructure in terms of roads, public transport and
electricity supplies is poor.
Methods
For inclusion in this study, patients had to have POAG,
have lived in the catchment area for at least 6 months, be
aged ≥30 years, be a new glaucoma patient to the hospital
(i.e. including referrals), be English or Hausa speaking and
willing to participate. Those with additional causes of
visual loss were excluded.
Potential participants were identified by examination
based on symptoms at presentation, or by routine disc
examination of all patients aged ≥30 years. For the latter,
undilated disc examination was performed by direct
ophthalmoscopy by one of two senior ophthalmic nurses
or optometrists trained in optic disc examination. Anyone
with a vertical cup:disc ratio (VCDR) of ≥0.6 was referred
to the ophthalmologist (MA) for detailed examination.
This VCDR was selected as data from the Nigeria national
survey of blindness where a VCDR of 0.7 was identified as
the cut-off for defining level 1 evidence of structural disc
damage due to glaucoma [11]. Examination included pre-
senting and unaided distance visual acuity (VA) measured
in each eye by an ophthalmic nurse using a Snellen E
chart. Best corrected VA was assessed using readings from
an autorefractor (Takagi, Japan); the swinging flashlight
test was performed for relative afferent pupillary defects,
and anterior segments were examined at the slit-lamp
(CSO, Italy). Other assessments included Von Herrick’s
peripheral anterior chamber depth, IOP measurement
(Goldman applanation tonometry), gonioscopy where
possible, and optic disc examination using a 60D lens
to assess VCDR, cup disc asymmetry and the presence
of splinter haemorrhages or a notch. If slit lamp disc
assessment was not possible, discs were examined by
dilated binocular indirect ophthalmoscopy. Automated
perimetry was performed using the screening program
of the Oculus Twinfield visual field analyser (VFA)
followed by threshold testing if defects consistent with
glaucoma were detected. The diagnosis of POAG was
made using internationally accepted guidelines [12]
based on VCDR, visual field defect (VFD), IOP and an
open angle on gonioscopy. Those confirmed with glau-
coma who were eligible were recruited after taking
written informed consent.
Glaucoma was graded by eye, and then by person
using the worst affected eye. The following definitions
were used: end stage: VA hand movement or worse and
VCDR of 1.0; advanced: central VF of <100 or VA < 3/60
in the presence of VCDR >0.8; moderate: central VF
10-200 with VCDR >0.7 with any level of VA; mild: any
other glaucomatous VFD and a VCDR >0.7. A VCDR
of >0.7 was used as this defined the 95th percentile in
the Nigeria national survey normative dataset [11]. In
our study advanced and end stage disease both fulfil
WHO VA and VF categories of blindness.
Table 1 Visual acuity in the better eye among patients presenting to eye units with glaucoma in African countries
Country Year N Age (mean years) % Blind Other findings
Northern Ghana [7] 1990 397 ND 52 % blind (VAc)
Dar es Salam, Tanzania [38] 2005 298 57 29 % blind (VAc) CDR ≥0.8: 70 %
Ethiopia [39] 2006 1,586 52 41 % blind (all glaucomas)
Benin, Nigeria [40] 2006 154 53 25 % blind (VAc)
56 % blind (VFAc) 7
Nigeria, Kano [41] 2007 71 18-75s 21 % blind (VAc) Mean CDR 0.9;
CDR ≥0.9: 30 %
Yaoundé, Cameroon [42] 2008 184 62 34 % blind (VAc)
Dar Es Salam, Tanzania [6] 2009 163 67 Operated eyes: 47 % blind; Pre-operative
93 % VA <6/60 CDR 0.8: 85 %
Upper East Region, Ghana [43] 2010 446 34 No data CDR > 0.8: 70 %
CDR = 1.0: 54.9 %
Nigeria: This study 2010 131 53 35 % blind (Vac) Mean CDR: 0.8
CDR = 1.0: 44 %
CDR = cup:disc ratio; VAc = visual acuity criterion - presenting acuity <3/60 in the better eye; VFAc = visual field analysis criterion - central visual field of <10
degrees; PL = light perception; NPL = no light perception
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The following information was obtained by interview:
age, sex, literacy, occupation, distance from residence to
the hospital, family history of visual loss or glaucoma,
whether they knew they had glaucoma and if so, when
and where it was diagnosed and previous treatment. Par-
ticipants were asked what they knew about glaucoma
and its treatment, and responses were graded using a
four-point scale ranging from poor (i.e. they had never
heard of glaucoma) through to excellent (i.e. they knew
it is associated with high IOP or causes optic nerve dam-
age or VFD). Knowledge of treatment was categorized as
poor if they knew nothing about it through to excellent
if they knew that glaucoma is treatable and could name
a treatment.
Participants were offered treatment after explaining
the condition and treatment options, taking account of
the stage of disease, other clinical parameters and socio-
economic factors. Whether they agreed to the treatment
recommended was recorded as well as reasons for not
agreeing. Participants agreeing to surgery were started
on topical treatment and given a date within two months
to attend for surgery. Those recommended topical treat-
ment were asked to re-attend in one month for IOP
measurement and to assess adherence to medication.
Adherence was assessed verbally and categorised as ex-
cellent if they had only missed very few doses, average,
or very poor if they took only few to no doses.
Ethical approval was obtained from the ethical and
research committees at London School of Hygiene &
Tropical Medicine and ATBUTH. This study adhered to
the tenets of the declaration of Helsinki.
Data analysis
Data were entered and analysed using Stata 11.2 StataCorp
LP. The eye with the most advanced glaucoma was used
in the analysis for comparison with other studies. Data
were analysed using two levels of severity: end-stage plus
advanced, and mild plus moderate glaucoma. Age was cat-
egorized as ≥50 years and <50 years. Univariate and multi-
variate analyses were undertaken to assess associations
between stage of disease and mode of presentation, age,
sex, ethnicity, distance to place of residence, literacy, occu-
pation and family history of glaucoma.
Results
During the study (May-Sept 2010) 6,291 patients
attended the outpatient department, 1,692 of whom
were aged ≥30 years. 209 individuals were examined by
the ophthalmologist based on a VCDR ≥0.6 in one or
both eyes, 131 of whom were diagnosed with POAG i.e.
7.9 % (131/1692) of adult clinic attendants. The mean
age of the 131 participants was 52.8 years (range 30-87
years), 62 % were male and 111 (90 %) had bilateral glau-
coma (Table 2).
Mode of presentation
Most participants attended because of symptoms (n = 92,
70 %), 18 (15 %) were formally referred with a diagnosis of
glaucoma, 10 (8 %) were identified by the optometrists as
they had a VCDR of ≥0.6, and 11 (8 %) were first-degree
relatives of individuals with POAG who attended for
assessment. Fifteen of the 18 referrals (14 % overall) were
already receiving treatment as were 43/92 (33 % overall)
presenting with symptoms. Sixty one participants there-
fore had a previous diagnosis of glaucoma, and 70 where
newly diagnosed.
Clinical findings at presentation
Visual field testing was not possible in 73 (56 %) partici-
pants on account of loss of fixation or poor comprehen-
sion or manual dexterity. Intraocular pressures in all eyes
with POAG ranged from 10 – 68mmHg (mean 31.9 +/-
SD 12.4). The mean IOP of eyes already on treatment was
lower than those not being treated (27.3mmHg, range 10-
55mmHg versus 32.1mmHg, range 12–68mmHg). Mean
VCDR in all eyes with POAG was 0.8 and 44 % of eyes
had aVCDR of 1.0 (Fig. 1). 99 eyes (47 %) had a presenting
VA of light perception or no light perception. 46 individ-
uals (35 %) were blind in their better seeing eye (present-
ing VA <3/60). Overall 100 (76 %) participants were blind
from glaucoma using WHO criteria i.e. had end stage or
advanced glaucoma.
Forty-seven participants (36 %) had a positive history
of blindness in their family, 29 of whom (22 %) gave a
definite family history of glaucoma. The majority of pa-
tients (83 %) had poor awareness about glaucoma and
how it is treated.
Risk factors for advanced or end stage disease
In univariate analysis the following were associated with
advanced or end stage disease in the worse eye: age >50
years, living >10 km from the hospital, some awareness
of glaucoma, not being literate, being unemployed or a
housewife and presenting with symptoms (Table 3). In
multivariable analysis age and poor knowledge of glau-
coma were independent risk factors for late presentation.
Participants living more than 10km from the hospital were
2.94 times more likely have advanced/end-stage disease
but this did not reach statistical significance (OR 2.94,
95 % confidence interval (CI) 0.93-9.32, p = 0.067). Living
in urban areas (OR 0.35 95 % CI 0.11-1.07, p = 0.067) was
protective in univariate analysis but this did not reach stat-
istical significance. Findings were similar for least affected
eyes (data not shown).
Acceptance of surgery and adherence to medical
treatment and follow up
Forty six participants were offered treatment for pain con-
trol for end stage disease and 85 were offered treatment to
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Table 2 Characteristics participants with POAG, by stage of glaucoma at presentation in the most affected eye
Mild/Moderate Advanced/End stage Total
N % N % N %
Mode of presentation Symptomatic 15 16 77 84 92 100
Referred 7 39 11 61 18 100
Opportunistic 6 60 4 40 10 100
First degree relative 3 27 8 73 11 100
Gender Male 19 23 62 76 81 100
Female 12 24 38 76 50 100
Age 50 years and above 10 13 70 87 80 100
Less than 50 years 21 41 30 59 51 100
Ethnic group Hausa 12 20 48 80 60 100
Other 19 26 52 73 71 100
Occupation Professional/civil servant/student/soldier/other 16 31 35 69 51 100
Traders/Artisans/farmers 12 24 37 76 49 100
Housewife/unemployed 3 10 28 90 31 100
Literacy Not literate 10 13 65 87 75 100
Literate 21 37 35 63 56 100
Family history of glaucoma Yes 10 34 19 66 29 100
No 21 21 81 79 102 100
Residence Urban 27 28 70 72 97 100
Rural 4 12 30 88 34 100
Place of residence Within 10 kms of hospital 25 30 56 70 81 100
10kms or more 6 12 44 88 50 100
Awareness of having glaucoma No 19 23 63 76 82 100
Yes 12 24 37 75 49 100
Knowledge about glaucoma Good 11 50 11 50 22 100
Poor 20 18 89 82 109 100
Total 31 24 100 76 131 100
Legend: VCDR-Vertical cup-disc ratio, IOP-Intraocular pressure
Fig. 1 Distribution of VCDR and IOP in participants with primary open angle glaucoma, by eye. Legend: VCDR-Vertical cup-disc ratio,
IOP-Intraocular pressure
Abdull et al. BMC Ophthalmology  (2015) 15:111 Page 4 of 8
preserve visual function. Among the latter, 14 were offered
topical treatment and 71 were offered trabeculectomy as
the treatment of choice. Only five (8 %) agreed to surgery.
Reasons for not accepting surgery included fear (37 %),
wanting to continue current treatment (27 %), cost (15 %),
no time (6 %), being too old (4 %) or needed to consult
their family (4 %). Only one patient returned for trabecu-
lectomy. Among the 85 participants started on topical
medication, 32 (24 %) returned at one month. 72 % re-
ported excellent compliance but only 56 % of glaucomat-
ous eyes had an IOP of <21mmHg.
Discussion
The majority of patients in this study presented to hospital
because of symptoms, with many already blind in at least
one eye, which confirms the findings of other studies in
Africa. Our series of patients were far more likely to be
blind at presentation than cases who present to eye de-
partments were there are primary care providers such as
optometrists, who can detect and refer individuals sus-
pected as having glaucoma. For example, in a study from
the UK, 91 % of eyes had a visual acuity of 6/12 or better
at presentation [13].
In this study 38 % of patients were not aware they
had glaucoma before the study and only 17 % had any
knowledge about glaucoma, being similar to a study in
Ethiopia, [14] and many population based studies in
other parts of Africa and other regions of the world,
including industrialized countries [15–17]. The finding
that some patients already being treated for glaucoma
had poor knowledge of the condition reflects poor
counselling, which is a challenge in northern Nigeria as
there is not a local word in the Hausa language for
glaucoma. Lack of knowledge of glaucoma is greater
amongst people with low socioeconomic status [18]
who need to be targeted for interventions, as greater
knowledge of glaucoma has been associated with
greater adherence to treatment, in Oman for example
Table 3 Univariate and multivariable analysis of factors associated with advanced or end stage glaucoma at presentation, using the
most affected eye
Univariate analysis Multivariable analysis
OR 95 % CI P value OR 95 % CI P value
Sex Male 1.0 1.0
Female 0.97 0.42-2.22 0.942 0.85 0.25-2.92 0.795
Age Less than 50 years 1.0 1.0
>50 years 4.9 2.06-11.65 <0.001 3.45 1.24-9.58 0.017
Family history of glaucoma Positive 1.0 1.0
Negative 0.53 0.21-1.29 0.16 0.39 0.12-1.28 0.122
Distance to hospital 10 km or less 1.0 1.0
More than 10km 3.27 1.24-8.67 0.017 2.74 0.75-10.09 0.129
Knowledge about glaucoma Poor 1.0 1.0
Good 0.22 0.08-0.59 0.002 0.27 0.80-0.92 0.036
Literacy Literate 1.0 1.0
Not literate 3.9 1.65-9.19 0.002 2.19 0.69-6.92 0.180
Awareness of having glaucoma Yes 1.0
No 1.07 0.46-2.46 0.864 NS
Ethnicity Hausa 1.0
Other 0.80 0.52-1.24 0.327 NS
Occupation Professional/civil servants etc. 1.0
Traders/Artisans/farmers 1.40 0.58-3.39 0.301 NS
Housewife/unemployed 4.27 1.12-16.12 0.032 NS
Mode of presentation Referred 1.0
Symptomatic 3.26 1.09-9.78 0.034 NS
Opportunistic 0.42 0.87-2.06 0.288 NS
First degree relative 1.69 0.33-8.67 0.525 NS
Residence Rural 1.0
Urban 0.35 0.11-1.07 0.067 0.65 0.15-2.79 0.56
OR = odds ratio; 95 % CI = 95 % confidence interval; NS = not statistically significant
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[19]. Indeed, poor knowledge has also been reported
among eye health workers [20].
In this study older age and poor knowledge of glaucoma
were independent risk factors for late presentation in
multivariable analysis. Living more than 10km from the
hospital increased the risk in univariate analysis, as did
not being literate, presenting with symptoms and being
unemployed. These associations did not reach statis-
tical significance in multivariable analysis, possibly
reflecting the relatively small sample size. Other studies
in Africa have shown a relationship between late pres-
entation of POAG with low levels of education and low
socioeconomic status, [21] but these factors were not
independent risk factors in our study. Greater awareness
needs to be created about glaucoma in the population to
promote earlier presentation.
Acceptance of surgical treatment for glaucoma is a
problem in Africa, [5, 6, 22] as was confirmed in this
study. In Tanzania, individuals identified with glaucoma
during a population-based survey were referred for tra-
beculectomy. Acceptance of trabeculectomy was 46 %
lower than cataract surgery (80 %) but nevertheless high
for glaucoma in Africa. Many patients in Africa do not
understand why they are offered surgery in the better
eye, particularly if they are already blind in the other
eye. In addition, the Hausa word for surgery, which
translates as butchering, has very negative connotations.
Acceptance of eye surgery is also poor for other eye con-
ditions e.g., for trichiasis surgery [23] and rumours can
play a role in patient’s decision making [24].
A trial in India demonstrated that acceptance of treat-
ment increased with education [25]. Implications are that
counselling or heath education, which dispels rumours
and overcomes fear can improve acceptance of treatment.
Counselling techniques such as Motivational Interviewing,
shown to be promising in a range of conditions [26–28],
could play a role. The aim of Motivational Interviewing is
to explore and resolve patient’s ambivalence and promote
his or her own motivation for change. This hypothesis is
currently being explored in a randomised trial of surgical
interventions for glaucoma in ATBUTH, Bauchi [29].
Adherence is defined by WHO as “the extent to which a
person’s behaviour corresponds with agreed recommenda-
tions from a health care provider” [30]. Self-reported
adherence in this study was relatively high at 72 %, but as
this did not correspond with IOP reduction this finding is
questionable. Adherence to treatment is a global problem.
Indeed, a National Health Service (United Kingdom)
report estimated that 30-50 % of prescribed medication is
not taken as recommended [31], and a study in the United
States of America showed that nearly half of patients
on ocular hypotensive therapy discontinued within six
months [32]. Non-compliance with glaucoma treatment is
common but more common in patients of African descent
[33]. Motivational interviewing may also have a role to
play in increasing adherence to topical medication for
glaucoma in Africa and other settings.
In our study only a quarter of patients attended follow
up at one month, which was lower than reported in
Ibadan, Nigeria [34]. In our study reasons for non-
attendance were not investigated but in the Ibadan study
reasons included lack of transport, fear of surgery, no
improvement with treatment, feeling better or no im-
provement with treatment. Similar findings have been
reported from India [35]. In the Ibadan study default
was more likely among younger patients, males and
those from long distances while those with severe
disease were more likely to attend. Poor follow up after
surgery has also been reported in Tanzania, for example
[22]. Poor knowledge has also been linked to poor follow
up among glaucoma patients [36].
The implications of our study are that counselling is
needed at the time of diagnosis so that patients under-
stand the purpose and importance of follow up. Our
study supports the recommendation of others of the
need for a once off treatment for glaucoma in Africa that
does not require regular follow up [5, 37].
This study demonstrates some of the problems en-
countered in managing glaucoma in Africa. Strategies
which promote earlier detection, such as opportunistic
screening or examination of first degree relatives,
coupled with counselling, may promote greater accept-
ance and adherence to treatment. Public awareness
needs to be increased while services and expertise are
being developed, which needs to include a once-off, rela-
tively non-invasive treatment of proven effectiveness
which is acceptable to patients, such as laser trabeculo-
plasty or transscleral diode laser cyclophotoablation.
In Africa, until glaucoma care becomes a sub-speciality
supported by technology for assessment, grading will need
to rely primarily on estimation of VCDR and VA, sup-
ported by VF assessment when possible, with the goal of
avoiding bilateral blindness. This is supported by our study
where only 36 % of patients were able to perform VF test-
ing well enough to allow glaucoma to be diagnosed based
on characteristic VFDs.
Strengths of this study are that it was a single centre,
prospective study, and one ophthalmologist undertook
all diagnostic examinations. Limitations include the rela-
tively small sample size and the diagnosis of glaucoma
was based mainly on VCDR and IOP as VF testing was
not possible in many participants.
Conclusion
Majority of glaucoma patients in Africa only report to hos-
pital when they have symptoms of loss of vision. This late
presentation coupled with poor adherence to medical
treatment and acceptance of surgery means that many
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continue to go blind despite reporting to hospital. To
prevent glaucoma blindness strategies are required which
promote earlier detection, with counselling to promote
acceptance of and adherence to treatment.
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